Frontlight ResearchEarly access
Trial site
Porto
- 6running trials
- 6closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis4 trials
- Chronic myeloid leukaemia2 trials
- Familial hypercholesterolaemia2 trials
- Metastatic breast cancer2 trials
- Aortic stenosis1 trial
- Coronary artery disease1 trial
- Heart failure1 trial
- Macular degeneration1 trial
- Melanoma1 trial
- Myelodysplastic syndromes1 trial
- Stroke1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Phase 1/21 trial
- Status
- Active, not recruiting3 trials
- Completed3 trials
- Recruiting3 trials
- Terminated3 trials
- Lead sponsor
- Novartis Pharmaceuticals12 trials
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting
Ofatumumab in Portuguese Multiple Sclerosis Patients - an Observational Study
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple sclerosis2 recruiting
- Aortic stenosis1 recruiting
- Familial hypercholesterolaemia1 recruiting
- Heart failure1 recruiting
Closed trials
Terminated
Terminated
Completed
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026